CASOLI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 1.780
AS - Asia 1.425
EU - Europa 1.175
SA - Sud America 156
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 4.614
Nazione #
US - Stati Uniti d'America 1.711
SG - Singapore 624
CN - Cina 519
UA - Ucraina 231
IE - Irlanda 216
SE - Svezia 202
FI - Finlandia 179
DE - Germania 126
BR - Brasile 124
HK - Hong Kong 111
VN - Vietnam 76
ZA - Sudafrica 56
CA - Canada 55
NL - Olanda 51
GB - Regno Unito 46
TR - Turchia 41
FR - Francia 40
IT - Italia 33
BE - Belgio 14
AR - Argentina 11
MX - Messico 11
BD - Bangladesh 9
IN - India 9
RU - Federazione Russa 9
EC - Ecuador 7
IQ - Iraq 7
AT - Austria 5
CO - Colombia 5
EU - Europa 5
PL - Polonia 5
ES - Italia 4
PK - Pakistan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
JP - Giappone 3
LT - Lituania 3
MA - Marocco 3
PY - Paraguay 3
CL - Cile 2
GA - Gabon 2
ID - Indonesia 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NO - Norvegia 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.614
Città #
Singapore 280
Jacksonville 232
Dublin 217
Chandler 204
Beijing 139
Ashburn 123
Santa Clara 114
Hong Kong 111
Dearborn 95
Boardman 94
Ann Arbor 82
Nanjing 69
Dallas 62
Johannesburg 55
Helsinki 49
Princeton 48
San Mateo 48
Shanghai 48
Los Angeles 41
Toronto 39
Izmir 38
Wilmington 34
Shenyang 22
Ho Chi Minh City 21
Hebei 20
Kunming 20
Seattle 20
Woodbridge 20
New York 18
Hefei 17
Nanchang 16
Brussels 14
Buffalo 14
Falkenstein 14
Jinan 14
Hanoi 13
São Paulo 13
Changsha 12
Tianjin 12
Guangzhou 10
Jiaxing 10
Norwalk 8
Rio de Janeiro 8
Auburn Hills 7
Haiphong 7
Chennai 6
Moscow 6
Parma 6
Stockholm 6
Atlanta 5
Bremen 5
Brooklyn 5
Columbus 5
Hải Dương 5
Montreal 5
Warsaw 5
Hangzhou 4
Houston 4
London 4
Munich 4
Rockville 4
San Francisco 4
Taiyuan 4
Tashkent 4
Abidjan 3
Amman 3
Baku 3
Belo Horizonte 3
Bắc Ninh 3
Denver 3
Formosa 3
Fortaleza 3
Ninh Bình 3
Nuremberg 3
Ponta Porã 3
Rome 3
Tokyo 3
Xian 3
Amsterdam 2
Ankara 2
Baghdad 2
Boston 2
Campinas 2
Centuripe 2
Charlotte 2
Curitiba 2
Da Nang 2
Des Moines 2
Duhok 2
Düsseldorf 2
Frankfurt am Main 2
Goiânia 2
Islamabad 2
Isorella 2
Joinville 2
Libreville 2
Luxembourg 2
Manchester 2
Montréal 2
Nairobi 2
Totale 2.729
Nome #
Biological insight into the mechanism of action of thiosemicarbazone complexes. 176
Copper(II) and Cobalt(III) Pyridoxal Thiosemicarbazone Complexes with Nitroprusside as Counterion: Syntheses, Electronic Properties, and Antileukemic Activity 153
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 142
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 133
THIOSEMICARBAZONES DERIVATIVES (TSCD) EFFECTS ON HIV, HTLV-1 AND HTLV-2 INFECTED CELLS 128
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 126
Striking changes of miRNAs expression in CD4+ T lymphocytes occurred even in the absence of an established HIV-1 infection. 122
HTLV-II influence on AIDS progression and changes in response to antiretroviral therapy in Italian IDUs coinfected with HIV-1 117
Exposure of TF-1 cells to HTLV-II induces the activation of STAT1 and STAT5 through the secretion of IFN-g and GM-CSF 117
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 112
HTLV-II infection exerts a protective role against AIDS progression in IDUs coinfected with HIV-1 112
HIV e riproduzione umana 108
Screening of HIV-1 Isolates By Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy 108
HTLV-II Downregulates HIV-1 replication in IL-2 Stimulated PBMC Cultures of Co-infected Individuals Through Expression of MIP-1a 107
Expression of cytokines and of chemokine receptors in PBMCs of HTLV-II mono-infected and HTLV-II/HIV-1 co-infected individuals 102
Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression? 101
Delayed progression to aids in HTLV-2/HIV-1 coinfected intravenous drug users 99
Epidemiological and molecular data on 170 HTLV-2 cases of Italian IDUs 98
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of CCL3L1 98
Azione concertata ELVIS: espressione selettiva della chemochina CCL3L1 in soggetti LTNP co-infettati da HIV-1 e HTLV-2 98
A dual defensive role of CIITA against retroviral infections 96
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures 94
Anti-CD4-GP120 complex antibodies in long term non progressors HIV-1 positive patients: a role in slowing disease progression?  94
Un mimotopo sintetico killer, attivo nei confronti di patogeni opportunisti correlati ad AIDS inibisce l’infezione esogena ed endogena di HIV 92
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of the CCL3/MIP-1alpha isoform L1/LD78beta 91
HTLV-2 influence on pathways regulating proliferation and death in B cell line BJAB 91
La coinfezione HIV-1/HTLV-II è associata ad un rallentamento della progressione AIDS 88
Up-regulation of the LD78b isoform of MIP-1a in PBMC cultures obtained from HTLV-2 infected/HIV-1 exposed seronegative individuals 88
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 87
Human T-cell Leukemia virus type II (HTLV-II) induces STAT1 and STAT5 activation in CD34+ TF-1 cells 85
Negative interference of HTLV-II on HIV-1 replication via CC chemokines 84
Retroviral cross-talk: HTLV-II Downregulates HIV-1 Replication from PBMC Cultures of Co-infected Individuals Via MIP-1a 84
Human T-cell leukemia virus type II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of Interferon-g and Granulocyte Macrophage-Colony Stimulating Facto 82
HTLV-II Replication inversely correlates with the expression of CIITA, the major regulator of HLA class II transcription 80
HTLV-II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of IFN-g and GM-CSF 80
PBMC expression of cytokines and chemokine receptors in relation to AIDS progression and HTLV-II co-infection 78
Selective CCL3L1/LD78b production by PBMCs during HTLV-2 infection induces resistance to HIV-1 entry 77
Serological and clinical follow-up of an Italian IVDU cohort of HTLV-II/HIV-1 co-infected patients. Evidence of direct relationship between CD4 count and HTLV-II proviral load 76
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 75
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells 75
The origin and evolution of Human T-cell Lymphotropic virus type II (HTLV-II) and the relationship with its replication 74
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 74
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 74
Specificity of the reverse Heteroduplex Mobility Assay (rHMA) for the identification of HIV-1 non-B clades in the new AIDS epidemic in Italy sustained by sexual transmission 73
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA, il regolatore trascrizionale dell’espressione dell’HLA-II 72
The MHC class II transactivator: prey and hunter in infectious diseases 71
The MHC Class II Transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection 69
Inhibition of human T cell leucemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y 62
Totale 4.623
Categoria #
all - tutte 16.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021218 0 0 0 0 0 4 48 4 91 11 56 4
2021/2022250 3 8 1 9 18 1 35 48 7 19 45 56
2022/2023786 92 96 51 63 66 70 12 37 262 4 22 11
2023/2024252 22 33 2 4 28 49 18 23 12 6 13 42
2024/2025870 4 56 59 52 75 148 4 18 152 82 49 171
2025/2026976 106 171 187 141 279 92 0 0 0 0 0 0
Totale 4.623